https://www.avient.com/sites/default/files/2022-10/Wall Partitions Mini Case Study.pdf
WALL PARTITION MANUFACTURER F O O D P R O C E S S I N G E N V I R O N M E N T S • Decrease growth of microbes on plastic surfaces that come in contact with food products • Compatibility with sheet extrusion processing • Maintain all other functional attributes inherent to product, such as ROHS, flame retardant standards, and specific brand color • Seamlessly incorporated multifunctional additives for optimal performance in reducing microbe growth • Developed custom formulation for complex processing configurations in sheet extrusion technology • Provided expertise in antimicrobial performance, chemical resistance, flame retardance, and regulatory product stewardship Cesa™ WithStand™ Antimicrobial Additives and Smartbatch™ Combination Colorants and Additives KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2025-05/Smartbatch Shampoo _ Conditioner OEM Case Study Snapshot.pdf
CONSUMER PACKAGED GOODS COMPANY S H A M P O O & C O N D I T I O N E R B O T T L E S A N D C A P S • Achieve a precise color match while ensuring a high amount of post-consumer recycled content (PCR) in the inner layer of the bottle • Reduce development time for quicker approvals and lower costs, and to enable rapid speed to market • Used proprietary Color Prediction Tool to digitally illustrate color possibilities while developing a customized PCR solution • Leveraged Avient’s ColorWorks Design & Technology Center to adjust colors according to the customer’s specifications and accelerate commercialization Smartbatch Combination Colorants & Additives KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2025-01/Stethoscope Dispersions Case Study Snapshot.pdf
MEDICAL DEVICE MANUFACTURER S T E T H O S C O P E S • Provide a silicone paste colorant dispersion for liquid silicone rubber (LSR) to use in stethoscope ear tips • Create a custom-colored vinyl plastisol formulation for stethoscope tubing • Harmonize color across materials to meet specific process and performance requirements • Deliver effective communication and cross-functional collaboration • Offered dependable silicone paste colorants that allowed for comfort and easy sterilization • Provided a colored vinyl plastisol to reduce tackiness and support product longevity • Collaborated internally to align all materials and provide color consistency across components • Supported fast color changes and met quality specifications through constant communication and technical expertise Silcopas Silicone Paste Colorants and CORE Vinyl Plastisols for Healthcare KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2020-10/avient-design-impact-protection-project.pdf
IMPACT PROTECTION D E S I G N A N D M A T E R I A L S O L U T I O N S Avient Corporation 1 PROJECT KICK OFF B R I E F Application: Protective sports equipment Challenge: Provide functional material to protect against impact for chest protector Requirements: • Compact - reduce thickness and weight for improved comfort and functionality • Meet EN standards • EN1621-1 level 2 & EN1621-2 level 1 • Eliminate the use of foam and glue • Be waterproof and easy to clean • Sustainable • Easy to prototype & considers manufacturing efficiency Avient Corporation 2 VIBRATION DAMPING TECHNOLOGY (VDT) H O W D O E S I T W O R K ?
Avient Corporation 3 Simplified Drop Test • 65g steel ball • Dropped from 305mm • Onto 3.175mm thickness flat samples Materials Tested • Standard TPE 30 Shore A • TPU alloy 60 Shore A • Damping TPE 32 Shore A VDT reduces bounce Avient Corporation 4 SIMULATION & CALIBRATION E N 1 6 2 1 - 1 L E V E L 2 Image courtesy of Airobag TV https://www.youtube.com/c/AirobagTV/videos Simulation of Impact A weight dropped onto protective element in contact with rigid substrate https://www.youtube.com/c/AirobagTV/videos Avient Corporation 5 SIMULATION & CALIBRATION E N 1 6 2 1 - 1 L E V E L 2 REFINING THE DESIGN D E S I G N A N D M A T E R I A L C O M B I N A T I O N Avient Corporation 6 • A number of different shapes and designs are created and simulated to determine which one works best • Refining to meet EN standard • VDT TPEs can help reach compliance with EN1621-1 level 2 and EN1621-2 level 1 • Optimum protection can be achieved by combining industrial design and engineering Avient Corporation 7 VALIDATION P R O T O T Y P I N G W I T H 3 D P R I N T I N G 3D Printing Validation -15% -10% -5% 0% 5% 10% Density Tensile Strength // Tear resistance // Rebound resilience 2mm 3D Printed VDT vs Injection Molded VDT can be 3D printed for concept evaluation early in the design process SUMMARY Avient Corporation 8 • Enabled a new, compact design with a customized VDT TPE formulation • Improved user comfort and functionality • Fulfilled EN standards • Reduced number of prototyping tools required • Reduced time spent in product development by 40 percent, enabling faster commercialization of product
https://www.avient.com/sites/default/files/2023-06/AVNT June IR Conferences w_Non GAAP Recs.pdf
Microsoft PowerPoint - AVNT June IR Conferences_6.1.2023 1130AM AVIENT CORPORATION I N V E S T O R P R E S E N T A T I O N (NYSE: AVNT) J U N E 2 0 2 3 DISCLAIMER Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
Avient Specialty Formulators Other Specialty / Chemical Companies 2023E(%) 37 79 89 83 81 76 73 90 82 77 76 74 70 58 22 A vi en t K W R P P G F U L A V Y R P M F M C C E H X L A S H E C L H U N E M N S C L MULTIPLE EXPANSION Avient Specialty Formulators Other Specialty / Chemical Companies Source: Peer data per Bloomberg as of May 31, 2023 Note: Avient reflects 2023 adjusted EBITDA guidance of $530M and closing share price of $36.50.
Avient 2011 and 2018 valuations reflect trailing 12 months EBITDA at December 31 of the respective years. 38 EV / 2023E EBITDA Historic Multiple 6.5 8.3 9.6 13.2 13.0 12.8 11.3 8.6 17.9 16.8 10.7 8.8 8.8 8.7 7.5 6.9 A vi en t (2 01 1) A vi en t (2 01 8) A vi en t (2 02 3) K W R P P G R P M A V Y F U L E C L H X L F M C S C L C E A S H E M N H U N Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.
https://www.avient.com/sites/default/files/2023-03/AVNT Q2 2022 Earnings Presentation - Website Version.pdf
Microsoft PowerPoint - AVNT Q2 2022 Earnings Presentation AVIENT CORPORATION S E C O N D Q U A R T E R 2 0 2 2 R E S U L T S (NYSE: AVNT) J U LY 2 6 , 2 0 2 2 DISCLAIMER 2 Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
D I S T R IBU T I O N) 18 END-MARKET FOCUS FOR NEW INNOVATION Semiconductors Robotics Healthcare Interconnected disruptive markets with massive innovation needs 19 APPENDIX Performance Additives 15% Pigments 13% TiO2 11% Dyestuffs 3%Polyethylene 12% Nylon 6% Polypropylene 5% Other Raw Materials 30% Styrenic Block Copolymer 5% ~40% hydrocarbon based (Grey shaded materials are hydrocarbon based, includes portion of “Other Raw Materials”) Non-hydrocarbon based materials 22 • Significant raw material price inflation and tight inventory continued in Q2 2022, although at a slightly lesser rate compared to the prior quarter o For Q2 2022, the average cost of key hydrocarbon based materials was up 15%, roughly the same as the average cost of non- hydrocarbon based materials. • Continued supply chain challenges persisted during Q2 related to raw material spot purchases, freight constraints and productivity loss as a result of these shortages.
Annual Purchases RAW MATERIAL AND SUPPLY CHAIN UPDATE Based on 2021 purchases, excludes Distribution business SEGMENT DATA U.S. & Canada 50% EMEA 25% Asia 16% Latin America 9% 2021 SEGMENT, END MARKET AND GEOGRAPHY GEOGRAPHY REVENUESEGMENT FINANCIALS Consumer 23% Packaging 19% Industrial 16% Building and Construction 10% Telecommunications 4% Energy 2% END MARKET REVENUE (1) Total company sales and adjusted EBITDA of $4,819M and $581M, respectively, include intercompany sales eliminations and corporate costs $2,402M $409M $919M $164M $1,631M $94M Sales EBITDA Distribution Specialty Engineered Materials Color Additives and Inks $581M$4,819M (1) Transportation 11% Healthcare 15% 24 Packaging 34% Consumer 21% Healthcare 8% Industrial 16% Building & Construction 10% Transportation 9% Energy 1% Telecommunications 1% C O L O R , A D D I T I V E S & I N K S 2021 REVENUE | $2 .4 BILL ION US & Canada 32% EMEA 40% Asia 21% Latin America 7% END MARKET REGION 25 All charts reflect 2021 financials S P E C I A LT Y E N G I N E E R E D M AT E R I A L S Consumer 27% Healthcare 10% Packaging 7% Telecommunications 16% Transportation 11% Industrial 11% Building & Construction 11% Energy 7% 2021 REVENUE | $919 MILLION END MARKET US & Canada 55% EMEA 25% Asia 20% REGION 26 All charts reflect 2021 financials D I S T R I BU T I O N Healthcare 26% Consumer 23% Packaging 5% Industrial 20% Transportation 16% Building and Construction 8% Energy 1% Telecommunications 1% US & Canada 80% Asia 3% Latin America 17% END MARKET REGION K E Y S U P P L I ER S 2021 REVENUE | $1 .6 B ILL ION 27 All charts reflect 2021 financials TOTA L C O M PA N Y R E G I O N A L S A L E S BY END MARKET Packaging 30% Consumer 26%Healthcare 13% Industrial 14% Building & Construction 5% Telecommunications 2% Energy 2% Asia (16% of sales) Transportation 8% Packaging 32% Consumer 13% Healthcare 5% Industrial 17% Building & Construction 12% Telecommunications 5% Energy 4% EMEA (25% of sales) Transportation 12% 28 Consumer 25% Healthcare 19% Packaging 10% Industrial 17% Building & Construction 10% Telecommunications 4% Energy 2% US & Canada (50% of sales) Transportation 13% Packaging 38% Consumer 33% Healthcare 8% Industrial 10% Building & Construction 5% Telecommunications 1% LATAM (9% of sales) Transportation 5% All charts reflect 2021 financials Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.
https://www.avient.com/sites/default/files/2022-11/AVNT Q3 2022 Earnings Presentation - Website Final.pdf
Microsoft PowerPoint - AVNT Q3 2022 Earnings Presentation AVIENT CORPORATION T H I R D Q U A R T E R 2 0 2 2 R E S U L T S (NYSE: AVNT) N OV E M B E R 2 , 2 0 2 2 DISCLAIMER Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
Purchase price multiple rapidly declining on strength of business and synergy capture 7 $133 $201 2019PF 2022E 7 Clariant Color EBITDA Growth Purchase Price Multiple 10.8x 7.0x 6.4x 2019PF 2021 2022E w/ Full Synergies (1) (1) 11.9% 16.3% 2019PF 2022E EBITDA Margins (1) CLARIANT COLOR: TRANSFORMATIONAL ACQUISITION ($ in millions) (1) Financial information is pro forma to include a full year of Clariant Color business SUNBELT PVC Resins DSS 20 Acquisitions $4.8B Investment $2.7B of Annual Revenue 5 Divestments $2.3B Proceeds TPE PP&S HISTORIC SPECIALIZATION THROUGH M&A 8 Distribution DSM Protective Materials BOLT-ON ACQUISITION HISTORY 9 Commercial Resources Operating Income ($ in millions) Operating Margins 259 363 At Acquisition 2022E $40 $139 At Acquisition 2022E 9% 22% At Acquisition 2022E Established Acquisitions (> 7 years) + 40% + 248% + 1300 bps I N V E S T T O G R O W SPECIALTY TRANSFORMATION T O D A Y 7% 46% 67% 86% 100% 0% 20% 40% 60% 80% 100% 2005 2010 2019 2021 2022 PF % o f A d ju st ed E B IT D A • Commodity JVs • Distribution • Performance Products & Solutions • Specialty Businesses (1) Adjusted EBITDA is EBITDA excluding corporate costs and special items (2) Pro forma for the acquisition of Dyneema® and divestiture of Distribution (1 ) (2) 10 Healthcare 4% Packaging 8% Consumer 10% Building & Construction 43% Industrial 15% Transportation 14% Energy 4% Telecom. 2% 2006 2022 Pro Forma Healthcare 8% Packaging 23% Consumer 21% Building & Construction 10% Industrial 15% Transportation 9% Energy 4% Telecom. 4% Defense 6% END MARKET FOCUS ON LESS CYCLICAL INDUSTRIES 11 14.8% 17.6% 21.0% 2018 2020 2022 PF 1.8% 2006 15.3% 16.2% 17.0% 2018PF 2020PF 2022E CAI 2.7% 2006 SEM SPECIALTY EBITDA MARGIN EXPANSION 12 • Portfolio transformation accelerates growth in less cyclical, higher margin end markets • Investments in our composites platform continue to drive margin expansion (1) (1) (1) 2018 and 2020 financial information is pro forma to include a full year of Clariant Color acquisition PORTFOLIO EVOLUTION OVER THE YEARS 13 Adj.
Sales EBITDA Specialty Engineered Materials Color Additives and Inks $585M$3,635M (1) Transportation 9% Healthcare 8% 23 C O L O R , A D D I T I V E S & I N K S 2022 REVENUE | $2 .3 B ILL ION US & Canada 35% EMEA 40% Asia 20% Latin America 5% END MARKET REGION 24 Packaging 33% Consumer 22% Healthcare 9% Industrial 15% Transportation 8% Building & Construction 11% Telecommunications 1% Energy 1% Figures represent 2022 full year estimates S P E C I A LT Y E N G I N E E R E D M AT E R I A L S 2022 PRO FORMA REVENUE | $1 .3 B ILL ION END MARKET US & Canada 50% EMEA 35% Asia 15% REGION 25 Figures represent 2022 full year estimates Packaging 5% Consumer 19% Healthcare 8%Industrial 16% Transportation 10% Telecommunications 10% Energy 9% Defense 15% Building & Construction 8% Packaging 31% Consumer 28% Healthcare 8% Industrial 13% Building & Construction 5% Telecommunications 3% Energy 2% Defense 1% Asia (20% of sales) Transportation 9% 2022 PROFORMA AVIENT REGIONAL SALES BY END MARKET Packaging 29% Consumer 13% Healthcare 5% Industrial 17% Building & Construction 11% Energy 5% Defense 7% EMEA (35% of sales) Transportation 10% Packaging 14% Consumer 23% Healthcare 11% Industrial 15% Building & Construction 12% Energy 5% Defense 7% US & Canada (40% of sales) Transportation 7% Packaging 49% Consumer 22% Healthcare 8% Industrial 9% Building & Construction 6% Telecommunications 1% LATAM (5% of sales) Transportation 5% Telecommunications 3%Telecommunications 6% Figures represent 2022 full year estimates Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.
https://www.avient.com/sites/default/files/2024-05/AVNT Q1 2024 Earnings Presentation_For_Website_w_non-GAAP_5_6_1.pdf
Avient corporation first quarter 2024 results and 2024 financial guidance AVIENT CORPORATION F I R S T Q U A R T E R 2 0 2 4 R E S U L T S A N D 2 0 2 4 F I N A N C I A L G U I D A N C E (NYSE: AVNT) M AY 7 , 2 0 2 4 DISCLAIMER Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
For the same reasons, Avient is unable to address the probable significance of the unavailable information. 2 O P E N I N G RE MARK S 4 REGIONAL DEMAND TRENDS-TOTAL COMPANY Q 1 S A L E S V S P Y ( E X C L U D I N G F X ) 4 US & Canada Latin America EMEA Asia +2% -6% Flat +2% Avient ex.
FX -1.5% FX -0.5% Total Avient -2.0% Q 1 2024 RE S U LT S Q1 2024 PERFORMANCE VS.
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520Sidoti%2520wNonGAAP%2520Rec.pdf
• A reconciliation of each non‐GAAP financial measure with the most directly comparable GAAP financial measure is attached to this presentation which is co pa ab e G a c a easu e s attac ed to t s p ese tat o c s posted on our website at www.polyone.com.
Page 3 Strategy and Execution Drive Results 90% $22 $24 PolyOne Stock Price 50% 70% $18 $20 $22 S&P 500 (relative performance) 30% $12 $14 $16 S&P 500 (relative performance) ‐10% 10% $6 $8 $10 50% ‐30% $0 $2 $4 $ | ‐50%$0 2006 2007 2008 2009 2010 2011 2012 2013 Page 4 Four Pillar Strategy The World’s Premier Provider of SpecializedThe World s Premier Provider of Specialized Polymer Materials, Services & Solutions Page 5 Spartech – Compelling Strategic Rationale • Spartech expands PolyOne’s specialty portfolio with adjacent technologies in attractive end markets Bolt on acquisition with opportunity for global expansion as only Bolt‐on acquisition with opportunity for global expansion, as only 6% of Spartech’s revenues are outside of North America • PolyOne has a proven management team with a track record of transformational success • Preliminary synergy estimated at $65 million run rate by end of 3year 3 Significant opportunity to expand profitability by leveraging PolyOne’s four pillar strategy • Substantial potential share price appreciation for all shareholders f f ll / $ Accretive to EPS in first full year post‐acquisition / $0.50 once synergies realized Page 6 Mix Shift Highlights Specialty Transformation Old PolyOne Transformation 100% 2015 Target 80% In co m e* 65 – 75%40% 60% f O pe ra tin g 34% 43% 45% 65 75% 20% % o f 2%0% 2005 2008 2010 2012 2015 Specialty OI $5M $46M $87M $114M Target *Operating Income excludes corporate charges and special items JV's PP&S Distribution Specialty Page 7 Proof of Performance 2007 2012 2015 “Where we were” “Where we are” “Where we Where we were Where we are expect to be" 1) Operating Income % Specialty 3.2% 9.1% 12 – 16% PP&S 6.1% 9.0% 9 – 12% Distribution 3.0% 6.4% 6 – 7.5% 2) Specialty Platform sss% of Operating Income 20% 45% 65 – 75% 3) ROIC* ( ft t ) 7% 11% 15%3) ROIC* (after‐tax) 7% 11% 15% 4) Adjusted EPS Growth** N/A 4 yr CAGR = 55% Double Digit Expansion *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period **4 yr EPS CAGR calculated using 2012 adjusted EPS vs 2008 adjusted EPS Page 8 Proof of Performance Spartech Opportunity Intermediate PolyOne Spartech Opportunity 2006 2012 Today Goal “Where we were” “Where we are” “Where Spartech is”* “Where we can go”were are Spartech is can go Specialty Operating Margin 1.5% 9.1% 2.2% 8.0% – 10.0% Margin Page 9 *Pro Forma results include Spartech corporate allocations for FY12 ended November 3, 2012 At a Glance PolyOne Europe 14% Canada 8% Asia 5% Latin America 3% Distribution 2012 Revenues: $4.2 Billion* 2012 Revenues: $4.2 Billion* United States 70% 14% 5% PP&S 20%Specialty 57% 23% 70% Appliance 5% Building & HealthCare Transportation 16% Textiles 2% 1.02 1.20 $1.20 $1.40 ha re End Markets* EPS Growth g Construction 14% Wire & Cable 8% Consumer 8% Packaging 17% Industrial 11% Misc. 6% 9% 0.27 0 21 0.79 $0.40 $0.60 $0.80 $1.00 Ad ju st ed E ar ni ng s P er S Electrical & Electronics 4% 0.12 0.21 0.13 $0.00 $0.20 2006 2007 2008 2009 2010 2011 2012 Page 10 * Pro Forma includes FY2012 results for Spartech (11/03/12 YE) and Glasforms At a Glance Specialty U it d 2012 Revenues: $2.4 Billion* Solutions United States 59% Europe 23% Asia Canada 4% Asia 9% Latin America 5% Appliance 4% Building & C t ti HealthCare 5% Transportation 16% Textiles 2% % o f S al es 12-16% End Markets* Expanding Profits Construction 11% Wire & Cable 7% Electrical & Electronics Packaging 23% Industrial 7% Misc. 15% 1.5% 3.2% 4.3% 5.3% 8.4% 9.1% O pe ra tin g In co m e % 8.0% Electronics 4% Consumer 6% Page 11 2006 2007 2008 2009 2010 2011 2012 2015 O Target* Pro Forma includes FY2012 results for Spartech (11/03/12 YE) and Glasforms At a Glance Designed Structures and Solutions United States 2012 Revenues: $0.85 Billion* Solutions 84% Europe 2% Canada 7% Latin America 7% Appliance 4% Building & Construction 11% Wire & Cable Sign & Advertising 3% Recreation & Leisure 2% Pool & Spa 1% Distribution & Thermoform 8% Textiles 2% Operating Income % of Sales 2012 Revenue by Industry Segment* Expanding Profits** Wire & Cable 7% Electrical & Electronics 4% Consumer 6% Packaging 23%Industrial 7% Transportation 16% 3% 2.2% 8 ‐ 10% 7% Misc. 1% HealthCare 5% 2012 2015 Target Page 12 *Pro Forma includes FY2012 results for Spartech (11/03/12 YE) **Pro Forma results include Spartech corporate allocations for FY12 Positioned for Earnings Growth 2015 Target Rev: $5B Adj.
EPS: $2.50 Assumptions • High single digit organic revenue CAGR • Operating margins in mid range of 2015 targets • No global recession• No global recession • No investment in incremental PP&S capacity • Completion of 2‐3 midsize accretive acquisitions • No divestitures • Housing starts at 85% of 50 year norm by 2015 R i f t bl b l 3X N t 2012 $ • Remain comfortably below 3X Net Debt / EBITDA Page 13 Rev: $3.0B Adj.
https://www.avient.com/sites/default/files/2022-10/Omnicolor Case Study Plastic Molder.pdf
PLASTIC INJECTION MOLDER V A R I O U S M A R K E T S & A P P L I C A T I O N S • Ability to use a color concentrate in multiple resins • Low let down ratio (LDR) • Color consistency over time • Offered versatile solution across resins and in various molding methods • Provided range of 1-3% LDRs in four standard colors • Achieved consistent color in a variety of products and markets for over 10 years Omnicolor™ Multipurpose Colorants KEY REQUIREMENTS WHY AVIENT?